Ignite Creation Date:
2025-12-24 @ 4:54 PM
Ignite Modification Date:
2026-01-04 @ 2:27 PM
Study NCT ID:
NCT00250250
Status:
COMPLETED
Last Update Posted:
2011-05-20
First Post:
2005-11-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG
Sponsor:
Ferring Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
FE999905 CS002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Clinical Development Support
Old Organization:
Ferring Pharmaceuticals